Plavix® Resources

S&C Related Contents
>> Plavix
New England Journal of Medicine - Clopidogrel versus Aspirin and Esomeprazole to Prevent Recurrent Ulcer Bleeding
Recent studies published by the New England Journal of Medicine have linked Plavix® (clopidogrel bisulfate) to serious, life-threatening side effects including strokes, gastrointestinal bleeding, heart attacks, and other serious conditions.
If you or a loved one have taken Plavix® and experienced any side effects, you should contact us immediately. You may be entitled to compensation for your injuries and we can help.
Plavix® (clopidogrel bisulfate), manufactured and distributed by Sanofi-Aventis and/or Bristol-Myers Squibb is the sixth top selling drug in the United States with sales totaling $3.8 billion dollars.
Doctors commonly prescribe Plavix® in combination with aspirin as a preventative measure against strokes and heart attacks.
A recent study published by the New England Journal of Medicine has found, “although doctors believe the combination of Plavix® and aspirin should reduce the risk of a second heart attack, the combination not only does not help, but it nearly doubles the risk of death, heart attack or stroke in people with no history of heart disease. It was also found to be associated with increased risk for moderate and severe bleeding.”
Plavix Lawsuits Filed: Our California colleagues have recently filed a class action lawsuit claiming that the Defendants (manufacturers and distributors of Plavix®) “rushed the drug to market and then launched an aggressive marketing campaign touting Plavix® as providing greater cardiovascular benefits than aspirin, while being safer and easier on a person’s stomach.”
Furthermore and in part, the lawsuit also claims that the aforementioned assertions are not only false, but that the Company knew about the serious health complications from the use of Plavix® from its own studies and had been warned by the FDA repeatedly to stop its fraudulent advertising. “The company did not stop its misleading advertising, nor did it alert the public to the life threatening side effects of Plavix®.”
Plavix® has been linked to a large variety of side effects including, abdominal pain, coughing gout, chest pain, irregular heartbeat, pneumonia, severe headaches, sinus inflammation, and bone marrow damage. However, the most serious and life-threatening side effects include:
The Defective Drug Litigation Group at our law firm is an experienced team of trial lawyers that focus exclusively on the representation of plaintiffs in Plavix® side effect lawsuits. We are handling individual litigation nationwide and currently accepting new Plavix cases in all 50 states.
Attention Attorneys: We do not publish prior verdict/settlements. If you are an attorney and would like to refer us a case or for us to send you a profile of prior award judgments or average referral fees, please visit the attorney referral section of our website.
Free Confidential Case Evaluation
Toll Free 24 hrs/day (866) 588-0600
Secure 128-bit SSL Encrypted Email Communication - Click Here.
Secure 1024-bit SSL Encrypted Live Chat Communication - Click Here.
= Required Field
| New Data Show High Frequency Of Medical Claims For Gastrointestinal ... - Medical News Today A review of medical claims from more than 70 managed care plans showed that 6.2 percent of patients prescribed the antiplatelet medicine clopidogrel submitted at least one insurance claim for ulcer or gastrointestinal bleeding, according to data ... Lilly CEO: From lab coat to corner office - CNN Money NEW YORK (CNNMoney.com) -- Eli Lilly & Co.'s incoming chief executive believes his background in the laboratory provides the formula needed to fill the drugmaker's dwindling pipeline. "The sweet spot for me, in terms of knowledge of this business, is ... Cogentus Pharmaceuticals Completes $62.5 Million Private Financing - PR Newswire MENLO PARK, Calif., Dec. 20 /PRNewswire/ -- Cogentus Pharmaceuticals Inc. announced today that it has completed a private placement financing, raising $62.5 million to support the clinical development of the company's novel antiplatelet therapy CGT ... Drugs and Treatments - Plavix Oral - WebMD Selected from data included with permission and copyrighted by First DataBank, Inc. This copyrighted material has been downloaded from a licensed data provider and is not for distribution, except as may be authorized by the applicable terms of use ... FDA Approves New 300mg Loading Dose Tablet for PLAVIX(R) (clopidogrel ... - PR Newswire BRIDGEWATER and PRINCETON, N.J., Sept. 27 /PRNewswire-FirstCall/ -- Sanofi-aventis (Euronext: SAN) (NYSE: SNY) and Bristol-Myers Squibb Company (NYSE: BMY) announced today that the U.S. Food and Drug Administration (FDA) has approved a supplemental ... |